Certainly one of the first mechanisms of action of Fladrafinil in the human body requires its ability to promote the brain’s neurotransmitter programs by acting for a prodrug that metabolizes into modafinil although simultaneously inhibiting dopamine reuptake and affecting histamine and norepinephrine pathways.This method is especially appropriat